Anti-osteoclastic agent, denosumab, for a giant cell tumor of the bone with concurrent Paget's disease: A case report

Grants

Funding Acknowledgements

The authors would like to thank Ms. Deborah May, a Clinical Research Nurse of the Department of Orthopedics at St. Vincent's Hospital Melbourne, and Ms. Danielle Jenson, Administrative Support for the Bone and Soft Tissue Clinic at Peter McCallum Cancer